Your email has been successfully added to our mailing list.

×
0.0695970695970696 0.0915750915750916 0.139194139194139 0.139194139194139 -0.0256410256410256 -0.0256410256410256 0.0256410256410257 0.0160439560439561
Stock impact report

Ritter Pharmaceuticals initiates first pivotal Phase 3 trial for RP-G28 [Seeking Alpha]

RITTER PHARMACEUTICALS (RTTR) 
Last ritter pharmaceuticals earnings: 8/14 05:11 pm Check Earnings Report
US:NASDAQ Investor Relations: ritterpharmaceuticals.com/investors
Company Research Source: Seeking Alpha
Ritter Pharmaceuticals initiates first pivotal Phase 3 trial for RP-G28Ritter Pharmaceuticals (NASDAQ:RTTR) announced that the first patient has been enrolled in the first pivotal Phase 3 clinical trial of RP-G28.“The initiation of this Phase 3 clinical trial for RP-G28, called the “Liberatus” study, is an important milestone not only for the company, but potentially for the way lactose intolerance is treated,” said Andrew J. Ritter, co-founder and president of Ritter Pharmaceuticals, Inc. “To date, there are no prescription drugs available to treat this condition, and we believe that our approach of modulating the microbiome in the gut may have a tremendous impact on the day-to-day lives of millions who suffer from lactose intolerance. We look forward to providing further information and updates on the trial as they become available.”Press ReleaseClick to subscribe to real-time analytics on RTTRNow read:Aptinyx Proposes Final Terms For $80 Million IPO » Show less Read more
Impact Snapshot
Event Time:
RTTR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for RTTR alerts
Opt-in for
RTTR alerts

from News Quantified
Opt-in for
RTTR alerts

from News Quantified